Glenview Capital Management - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Glenview Capital Management ownership history of BAXTER INTL INC
ValueSharesWeighting
Q4 2022$102,448,324
-15.7%
2,009,973
-10.9%
2.27%
-25.3%
Q3 2022$121,563,000
-12.9%
2,257,019
+3.9%
3.04%
-12.9%
Q2 2022$139,573,000
-18.6%
2,173,019
-1.7%
3.49%
+0.6%
Q1 2022$171,444,000
-8.5%
2,211,036
+1.3%
3.47%
-13.1%
Q4 2021$187,339,000
+7.4%
2,182,422
+0.7%
3.99%
+26.2%
Q3 2021$174,350,000
+85.2%
2,167,722
+85.4%
3.16%
+103.1%
Q2 2021$94,136,000
-19.0%
1,169,387
-15.1%
1.56%
-20.9%
Q1 2021$116,220,000
+159.2%
1,377,998
+146.6%
1.97%
+91.5%
Q4 2020$44,841,000
+320.4%
558,832
+321.4%
1.03%
+206.9%
Q3 2020$10,666,000
+61.4%
132,623
+72.8%
0.34%
+84.1%
Q2 2020$6,607,000
-83.1%
76,738
-84.1%
0.18%
-82.9%
Q1 2020$39,197,000
+125.7%
482,786
+127.7%
1.07%
+579.0%
Q2 2019$17,367,000
-77.3%
212,055
-77.5%
0.16%
-77.0%
Q1 2019$76,495,000
+32.5%
940,778
+7.3%
0.68%
+22.2%
Q4 2018$57,724,000877,0010.56%
Other shareholders
BAXTER INTL INC shareholders Q4 2020
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders